Dermatology

A new retrospective study has shed light on the incidence of cutaneous pyogenic granulomas (PGs) by age, sex, and anatomical location.

Understanding why some patients with melanoma respond to immunotherapy while others do not has remained a critical challenge for precision medicine.

A recent clinical trial has shown promising results in treating severe, active vitiligo through a combination of oral medication and phototherapy, offering new hope for managing this challenging condition.

Fixed-combination topical therapies show improvements in acne within the first 4 weeks of treatment, according to new data compiled from pivotal clinical trials.

A groundbreaking clinical trial has provided valuable insights into the management of dermatoporosis, a condition characterized by chronic extracellular matrix (ECM) degradation leading to skin atrophy and fragility.

A recent large-scale study published in a dermatology journal provides important insights into the cardiovascular safety of biologic therapies for patients with psoriasis or psoriatic arthritis (PsA).

A new systematic review has shed light on the safety of beta blockers for treating PHACE syndrome, addressing concerns about stroke risk in patients with cerebrovascular and cardiovascular anomalies.

A recent study has highlighted metformin’s potential role in reducing the risk of non-melanoma skin cancers (NMSC), offering intriguing possibilities for dermatological and oncological care.